PHF Antibodies

Santa Cruz Biotechnology delivers a wide array of PHF Antibodies for the detection and analysis of phosphorylated tau protein aggregates, which are critical in the study of neurodegenerative diseases such as Alzheimer's. PHF monoclonal antibodies serve as versatile tools in various research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phosphorylated tau proteins play a significant role in stabilizing microtubules in neurons, and their aggregation into paired helical filaments (PHFs) is a hallmark of tauopathies. Understanding the dynamics of PHF formation and its implications in neurodegeneration is crucial for developing therapeutic strategies. PHF monoclonal antibodies enable researchers to investigate tau protein modifications and their impact on cellular function. Studying PHF formation provides valuable insights into the progression of neurodegenerative disorders. Research utilizing PHF monoclonal antibodies helps identify potential therapeutic targets and biomarkers. Santa Cruz Biotechnology's PHF monoclonal antibodies support researchers worldwide in advancing neurodegenerative disease research and developing potential treatments.